BBNX Stock Summary and Trading Ideas (Beta Bionics | NASDAQ:BBNX)

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

What symbol and exchange does Beta Bionics shares trade?

Beta Bionics trades on the NASDAQ stock market under the symbol BBNX.

What is Beta Bionics stock price doing today?

As of December 5, 2025, BBNX stock price declined to $29.38 with 914,190 million shares trading.

What is Beta Bionics's Beta?

BBNX has a beta of 1.32, meaning it tends to be more sensitive to market movements. BBNX has a correlation of 0.08 to the broad based SPY ETF.

How much is Beta Bionics worth?

BBNX has a market cap of $1.29 billion. This is considered a Small Cap stock.

How much money does Beta Bionics make?

Last quarter Beta Bionics reported $27 million in Revenue and -$.33 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.10.

What are the top ETFs holding Beta Bionics?

The top ETF exchange traded funds that BBNX belongs to (by Net Assets): VTI, IWM, VXF, IWO, IHI.

What are the support and resistance levels for Beta Bionics (BBNX)?

BBNX support price is $28.47 and resistance is $31.53 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BBNX shares will trade within this expected range on the day.